Followers | 839 |
Posts | 120509 |
Boards Moderated | 18 |
Alias Born | 09/05/2002 |
Thursday, May 02, 2024 4:22:37 PM
https://www.businesswire.com/news/home/20240502260564/en
VIR re-iterated guidance for 2024 operating expenses of $650-680M.
CC slides:
https://investors.vir.bio/files/doc_financials/2024/q1/Vir-Corporate-Presentation_Q1-2024.pdf
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent VIR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 12:10:48 PM
- Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer • Business Wire • 09/10/2024 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:29:38 PM
- Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers • Business Wire • 09/09/2024 08:05:00 PM
- Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/22/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:43:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:08:53 PM
- Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities • Business Wire • 08/01/2024 08:02:00 PM
- Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers • Business Wire • 08/01/2024 08:01:00 PM
- Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 • Business Wire • 07/18/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:40:36 PM
- Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection • Business Wire • 06/26/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 10:04:32 AM
- Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment • Business Wire • 06/05/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 04:13:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 03:57:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:43:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:42:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:06:02 PM
- Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 05/29/2024 08:05:00 PM
- Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer • Business Wire • 05/29/2024 12:05:00 PM
- Vir Biotechnology to Host 2024 Annual Meeting of Stockholders • Business Wire • 05/23/2024 08:05:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM